A Case of Coloboma in a Newborn to a Woman Taking Mycophenolate Mofetil in Pregnancy After Kidney Transplantation

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1407-1409

  dei Malatesta, M Framarino ^a   Rocca, B ^b   Gentile, T ^a   Hadjistilianou, T ^c   Borri, M ^c   de Francesco, S ^c   Pisani, F ^d   Famulari, A ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; COLOBOMA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FETUS OUTCOME; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; NEWBORN; NEWBORN DISEASE; OPHTHALMOSCOPY; PREGNANCY; PRIORITY JOURNAL; TERATOGENESIS; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; NUCLEAR MAGNETIC RESONANCE IMAGING;

COLOBOMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MYCOPHENOLIC ACID; PREGNANCY;

EID: 65549088397     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.088     Document Type: Article

References (11)

1. Tendron A., Gouyon J.B., and Decramer S. In utero exposure to immunosuppressive drugs: Experimental and clinical studies. Pediatr Nephrol 17 (2002) 121
2. Sollinger H.W., and US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60 (1995) 225
3. European Medicines Agency. 2007. CellCept, European public assessment report 2007 (EPAR). http://www.emea.europa.eu/humandocs/Humans/EPAR/cellcept/cellcept.htm
4. Sifontis N.M., Coscia L.A., Constantinescu S., et al. Pregnancy outcomes in solid organ trasplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82 (2006) 1698
5. Perez-Aytes A., Ledo A., Boso V., et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype?. Am J Med Genet A 146A (2008) 1
6. Armenti V.T., Radomski J.S., Moritz M.J., et al. Report from the national transplantation pregnancy registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transpl (2004) 103
7. Le Ray C., Coulomb A., Elefant E., et al. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 103 (2004) 1091
8. Ang G.S., Simpson S.A., and Reddy A.R. Mycophenolate mofetil embryopathy may be dose and timing dependent. Am J Med Genet 146 (2008) 1963
9. Kainz A., Harabacz I., Cowlrick I.S., et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 70 (2000) 1718
10. Ostensen M., Khamashata M., Lockshin M., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (2006) 209
11. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Longterm management of the transplant recipient. IV. 10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 17 Suppl 4 (2002) 50